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Abstract
Lactobacillus brevis is a technological additive intended to improve the ensiling process at a minimum
proposed dose of 1 9 108 colony-forming units (CFU)/kg fresh material. The species L. brevis is
considered by EFSA to be suitable for the qualiﬁed presumption of safety approach to safety assessment
and not to require speciﬁc demonstration of safety other than the susceptibility to antibiotics of human
and veterinary signiﬁcance. Although identity was established, the strain was found resistant to ampicillin
and clindamycin and may pose a risk for the spread of genes coding for resistance to these antibiotics.
Therefore, the use of this strain as a silage additive is not considered safe for target animals, and
consumers of products from animals fed the treated silage. In the absence of data, no conclusion can be
drawn on the skin and eye irritancy or skin sensitisation of the additive. The additive should be
considered as a potential respiratory sensitiser. Although L. brevis is ubiquitous in the environment, due
to its antibiotic resistance, the FEEDAP Panel cannot conclude on the extent of the risk of horizontal gene
transfer to other bacteria in the environment. Six studies with laboratory-scale silos were made using
forage of differing water-soluble carbohydrate content. Replicate silos containing forages treated at the
proposed application rate were compared to identical silos containing the same but untreated forage.
After opening and exposure to air, an increase of 3°C over ambient was taken to indicate aerobic
deterioration. The additive showed a potential to signiﬁcantly improve the aerobic stability of silage
produced from easy, moderately difﬁcult and difﬁcult to ensile forage at a minimum application rate of
1 9 108 CFU/kg plant material.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Bio-Competence Centre of Healthy Dairy Products
LLC2 for authorisation of the product Lactobacillus brevis NCIMB 42149,3 when used as a feed additive
for all animals species (category: Technological additives; functional group: Silage additives).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the
applicant the technical dossier in support of this application. The particulars and documents in support
of the application were considered valid by EFSA as of 4 August 2015.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety
for the target animals, consumer, user and the environment and on the efﬁcacy of the product
Lactobacillus brevis NCIMB 42149, when used under the proposed conditions of use (see
Section 3.1.4).
1.2. Additional information
The additive is a preparation containing viable cells of L. brevis NCIMB 42149. It has not been
previously authorised as a feed additive in the European Union.
The species L. brevis is considered by EFSA to be suitable for the qualiﬁed presumption of safety
(QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2013). This approach requires
the identity of the strain to be conclusively established and evidence that the strain does not show
acquired resistance to antibiotics of human and veterinary importance.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier4 in support of the authorisation request for the use of L. brevis NCIMB 42149 as a feed
additive. The technical dossier was prepared following the provisions of Article 7 of Regulation (EC)
No 1831/2003 and Regulation (EC) No 429/20085 and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active agent in animal feed. The Executive Summary of the EURL
report can be found in Annex A.
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of L. brevis
NCIMB 42149 is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant
guidance documents: Guidance on technological additives (EFSA FEEDAP Panel, 2012a), Technical
guidance on tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011), Guidance on
studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012b)
and Technical guidance on the update of the criteria used in the assessment of bacterial resistance to
antibiotics of human or veterinary importance (EFSA FEEDAP Panel, 2012c).
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Bio-Competence Centre of Healthy Dairy Products LLC., Kreutzwaldi 1, 51014 Tartu, Estonia.
3 In the mandate, the applicant identiﬁed the strain also with in-house identiﬁer TAK 124-1.
4 FEED dossier reference: FAD-2015-0014.
5 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
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3. Assessment
The additive under assessment is a preparation containing viable cells of L. brevis NCIMB 42149. It
is intended to be authorised as a technological additive (functional group: silage additive) for all animal
species.
3.1. Characterisation
3.1.1. Characterisation of the active agent
The strain of L. brevis was isolated from grass silage and is deposited with the National Collection
of Industrial, Food and Marine Bacteria (UK) with the accession number NCIMB 42149.6 It has not
been genetically modiﬁed. Strain identity was established by its phenotypic properties and by the full
16S rRNA gene sequence which by comparison with sequences recorded in databases gave an
unambiguous identiﬁcation.7
Genetic stability was examined by comparison of the enterobacterial repetitive intergenic consensus
region using polymerase chain reaction ampliﬁcation.7 Using this method, the master culture was
compared with production lots produced in 2011 and 2013. No differences in the resultant patterns
were observed. The strain contains three plasmids (10 kb, 7 kb and 6 kb).
The strain was initially tested for antibiotic susceptibility using the E-test. The battery of antibiotics
tested was that recommended by EFSA for obligate heterofermentative lactobacilli (EFSA FEEDAP
Panel, 2012c) excluding streptomycin and vancomycin which are not required for this species.8 Using
this method, all minimum inhibitory concentration (MIC) values for the L. brevis strain fell below the
corresponding cut-off values deﬁned by the FEEDAP Panel. However, when antibiotic susceptibility was
tested using a more reliable serial twofold dilution method in agar, the MIC values for tetracycline,
clindamycin and ampicillin exceeded the cut-off values used by EFSA.9 The MIC for tetracycline was
within one-dilution step and within the normal variation for the method and thus is not considered a
cause for concern. The MIC values for the remaining two antibiotics were outside the expected
variation (8 vs 2 mg/L for ampicillin and 8 vs 1 mg/L for clindamycin). Consequently, further studies
were made to elucidate the molecular basis of the resistance shown to these antibiotics. Genomic and
plasmid fractions were sequenced and searched for known resistance determinants in a consolidated
database derived from four public databases (CARD, ARDB, ResFinder and Lahey b-lactamase
database). A gene, LmrB, known to confer resistance to lincomycin was identiﬁed in the genomic
fraction but not in plasmid DNA, together with a number of genes encoding transport proteins/efﬂuent
pumps. Clindamycin belongs to the same class of antibiotics and is directly derived from lincomycin
and it seems probable that LmrB is responsible for the resistance shown to clindamycin as is the case
for Corynebacterium glutamicum (Kim et al., 2001). No genes encoding b-lactamases were found
although one chromosomal gene elsewhere annotated as a serine hydrolase was found to contain a
domain homologous with b-lactamase. The molecular basis for the resistance shown to ampicillin
remains unclear.
3.1.2. Characterisation of the product10
The manufacturing process is detailed in the dossier.11,12
The minimum content of L. brevis in the ﬁnal product is speciﬁed as 1 9 1011 colony-forming units
(CFU)/g additive. Analysis of ﬁve production batches showed a value of 1.4 9 1011 CFU/g additive for
each batch tested.13
Microbiological testing showed that ﬁlamentous fungi, yeasts, Escherichia coli, Clostridium
perfringens, total Enterobacteriaceae and Salmonella in three batches of the additive were absent or
below the set action limits.14 Routine microbiological testing is included at several stages in the
6 Technical dossier/Section II/Annex II.2-9.
7 Technical dossier/Section II/Annex II.2-1.
8 Technical dossier/Section II.
9 Technical dossier/Supplementary information August 2016/Annex II.2.
10 This section has been amended following the conﬁdentiality claims made by the applicant.
11 Technical dossier/Section II/Annex II.10.
12 Technical dossier/Section II/Annex II.3.
13 Technical dossier/Section II/Annex II.2.
14 Technical dossier and Supplementary information August 2016/Annexes II.4 and II.3.
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production process and for the ﬁnal product. The methods used are speciﬁed and action limits
described.15 However, the protocol for routine testing differs slightly from the data initially provided
and also includes Staphylococcus aureus and Listeria monocytogenes, but apparently excludes
Salmonella. Heavy metals (Pb, Cd and Hg) and arsenic were also analysed. Arsenic, mercury and lead
were below the limits of detection (LOD),16 cadmium was < 0.01 mg/kg. Aﬂatoxins B1, B2, G1 and G2,
zearalenone and deoxynivalenol were all below the LOD.17 On the basis of these results and
considering the medium constituents and excipients used in the production process, contamination by
heavy metals, arsenic or mycotoxins is not routinely monitored.
Dusting potential was measured using a Heubach dustometer for four batches of the additive.18
Each batch was tested once and a mean value of 1.82 g/m3 was obtained. One of the four batches
tested for dusting potential was also examined for particle size distribution by laser diffraction.18 The
mean particle size was ~ 130 lm with approximately 38% of the additive consisting of particles with
diameters below 100 lm, 19% below 50 lm and 4% below 10 lm.
3.1.3. Stability
Three batches of additive were examined for shelf-life when stored under different conditions.19 The
microbial count was made at time zero and after 3 days storage at 37°C/relative humidity (RH) 75%,
2 months at 20°C/RH 60, up to 21 months at 3°C and 24 months at 21.5°C. Counts indicated that the
additive was stable when stored at 20°C for at least 2 months but activity was reduced by one log after
3 days storage at 37°C. Counts were unaffected when the additive was stored under refrigeration (+3°C)
or frozen (21.5°C). The applicant recommends storage under refrigerated conditions before use.
Samples from three batches of additive were individually suspended in water at a rate of
1 g product/L water to give a minimum count of 1 9 108 CFU/L and maintained at 20°C for 48 h.
Counts of lactobacilli remained constant over this period.20
3.1.4. Conditions of use
The additive is intended for use with all forages and for all animal species at a proposed minimum
concentration of 1.0 9 108 CFU/kg fresh material, to be applied as an aqueous suspension.
4. Safety
4.1. Safety for the target species and consumers
L. brevis NCIMB 42129 is resistant to ampicillin and clindamycin, two antibiotics of clinical
importance, and consequently, the QPS approach to safety assessment cannot be applied. As the
resistance of the L. brevis strain to ampicillin and clindamycin is not established as intrinsic and as the
genetic basis of the observed resistance remains unclear, a potential for horizontal gene transfer
among bacteria cannot be excluded. Consequently, the use of L. brevis NCIMB 42129 is not considered
safe for the target animals and consumers of products from animals fed the treated silage.
4.2. Safety for the user
No data were submitted on skin/eye irritation or skin sensitisation. Therefore, no conclusions can
be drawn on the skin and eye irritancy or skin sensitisation of the additive. The particle size
distribution and the dusting potential of the single preparation tested indicated a possibility of users to
be exposed via inhalation. Given the proteinaceous nature of the active agent, the additive should be
considered a potential respiratory sensitiser.
Once an active agent has been authorised as a silage additive, different formulations can be placed
on the market with reference to that authorisation. The applicant listed several cryoprotectants which
would allow multiple formulations of the additive to be produced and consequently, not all forms can
be directly tested for user safety. However, for assessing the safety for the user of the additive, the
15 Action limits: yeasts and ﬁlamentous fungi < 102 CFU/g, E. coli < 102 CFU/g, total Enterobacteriaceae < 102 CFU/g,
Cl. perfringens absent in 1 g, and Salmonella absent in 25 g additive.
16 Limits of detection not speciﬁed.
17 Limits of detection: Aﬂatoxins B1, B2, G1 and G2: 0.4 lg/kg, zearalenone: 15 lg/kg and deoxynivalenol: 115 lg/kg.
18 Technical dossier/Section II/II.5.
19 Technical dossier/Section II and Supplementary information August 2016/II.22.
20 Technical dossier/Section II/Annex II.23.
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active agent is the principal concern provided that other components do not introduce safety issues.
For this speciﬁc product, the excipients used in the preparation of the ﬁnal formulation do not
introduce additional risks.
4.3. Safety for the environment
L. brevis is ubiquitous in the environment. However, due to the antibiotic resistance of this speciﬁc
strain, the FEEDAP Panel cannot conclude on the extent of the risk of horizontal gene transfer to other
bacteria in the environment.
5. Efﬁcacy
Six laboratory experiments were made with different forage samples. The duration of the
experiments was 90 days or longer (90–103 days). All of the studies used 3 L minisilos capable of
holding approximately 1.3 kg chopped forage material with the capacity to vent gas. In each case, the
contents of ﬁve replicate silos were sprayed with the additive at an intended dose of 1 9 108 CFU/kg
forage suspended in water. Each suspension was then analysed for the actual cell count and conﬁrmed
the intended dose in ﬁve of the six studies. However, in study 4, the actual dose (4 9 106 CFU/kg
forage) was substantially less than that intended. Forage for the negative control silos were sprayed
with an equal volume of water but without the additive. In addition, in ﬁve of the studies, replicate
forage samples were treated with formic acid as a positive control (studies 1–4 at 3 g/kg formic acid
and study 5 at 5 mg/kg). Laboratory silos were maintained at 20–24°C for the duration of the
experiment. The forages samples (see Table 1) used represented material difﬁcult to ensile (studies 121
and 222), moderately difﬁcult to ensile (studies 323 and 424) and easy to ensile (studies 525 and 626) as
speciﬁed by Regulation (EC) No 429/2008.
Replicate silos were opened at the end of the experiment and the contents were analysed for
proximate composition, dry matter content, pH, lactic acid and volatile fatty acid concentrations,
ethanol, ammonia and total nitrogen. Counts were also made of total ﬁlamentous fungi, yeasts and
Clostridium spores. Statistical evaluation of data shown in Table 2 was made by comparison with the
negative control using a one-sided non-parametric analysis (Wilcoxon Kruskal–Wallis test) with
signiﬁcance assumed at p < 0.05.
At the end of the ensiling period, the content of opened silos after sampling were transferred to an
insulated box and continuously monitored for temperature change. Temperature changes were
measured for either 216 h (9 days) in the case of studies 1–4 or 279 h (ca. 12 days) in studies 5 and
6. An increase of 3°C over ambient temperature was taken to indicate aerobic deterioration.
The results of the studies are shown in Table 2.
Table 1: Characteristics of the forage samples used in the six ensiling experiments
Study Test material
Dry matter
content (%)
Water-soluble
carbohydrate content
(% fresh matter)
1 Red clover, second cut 20.3 0.6
2 Timothy, ﬁrst cut 29.1 1.1
3 Ryegrass, ﬁrst cut 23.8 1.5
4 Ryegrass, second cut 26.6 2.9
5 Grass-legume mixture (50% festulolium(a), 15% white
clover, 20% timothy, 15% perennial ryegrass),ﬁrst cut
48.8 3.3
6 Festulolium(a), second cut 30.4 6.4
(a): A hybrid cross of Festuca pratensis and a Lolium sp.
21 Technical dossier/Section IV/Annex IV.3.
22 Technical dossier/Section IV/Annex IV.4.
23 Technical dossier/Section IV/Annex IV.1.
24 Technical dossier/Section IV/Annex IV.2.
25 Technical dossier/Section IV/Annex IV.5.
26 Technical dossier/Section IV/Annex IV.6.
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Addition of the additive at the recommended dose produced the effects expected of a
heterofermentative lactobacillus. Lactic acid production was signiﬁcantly increased in four of the six
studies and, more importantly, acetic acid in ﬁve of the six. This resulted in a signiﬁcantly lower pH in
four studies. However, this had little or no beneﬁt in terms of the direct preservation of nutritional
value. The value of addition was seen in an increase in aerobic stability of the silage after exposure to
air, which was seen in all studies. The time to detectable deterioration was signiﬁcantly increased in
ﬁve studies. The remaining study (study 5) also showed a numerical beneﬁt (from 186 to 279 h) but
this failed to reach signiﬁcance in the non-parametric test used.
Numbers of yeasts were signiﬁcantly reduced in treated silage in three of the studies. No signiﬁcant
differences were seen in counts of ﬁlamentous fungi and yeasts in the remaining studies between
treated and untreated silage. Silage from ﬁve of the six studies showed very low numbers of clostridia
and no treatment related effects were detectable. In the remaining study, clostridial numbers were
signiﬁcantly reduced in the L. brevis treated group.
Conclusions
L. brevis NCIMB 42149 is resistant to ampicillin and clindamycin and might pose a risk for the
spread of genes coding for resistance to these antibiotics of clinical importance. Therefore, the use of
this strain as a silage additive is not considered safe for target animals or consumers of products from
animals fed the treated silage.
In the absence of data, no conclusion can be drawn on the skin and eye irritancy or skin
sensitisation of the additive. The additive should be considered as a potential respiratory sensitiser.
L. brevis is ubiquitous in the environment. However, due to the antibiotic resistance of this speciﬁc
strain, the FEEDAP Panel cannot conclude on the extent of the risk of horizontal gene transfer to other
bacteria in the environment.
L. brevis NCIMB 42149 showed a potential to signiﬁcantly improve the aerobic stability of silage
produced from easy, moderately difﬁcult and difﬁcult to ensile forage at an application rate of
1 9 108 CFU/kg plant material.
Table 2: Summary of the analysis of ensiled material recovered at the end of the ensiling period
with Lactobacillus brevis NCIMB 42149 at 1 9 108 CFU/kg forage
Study Additive
Dry matter
loss (%)
pH
Lactic acid
(% DM)
Acetic acid
(% DM)
NH3-N
(% total N)
Aerobic stability
(h)(a)
1 0 10.3 5.9 2.2 2.1 11.6 113
L. brevis 8.2* 5.5* 4.4* 2.3 9.0* 197*
Formic acid 5.1* 4.8* 7.3* 2.4 7.1* > 216*
2 0 2.5 4.5 6.3 1.2 5.5 164
L. brevis 3.0* 4.5 6.4 2.4* 5.6 > 216*
Formic acid 2.0* 4.2* 6.6 1.1 7.4* 126
3 0 7.1 5.5 2.8 1.2 10.5 32
L. brevis 5.9* 4.8* 6.0* 2.8* 8.5* 99*
Formic acid 3.1* 4.5* 4.1* 0.9* 6.7* 59*
4 0 8.5 5.3 4.9 0.6 9.7 26
L. brevis 9.5* 4.7* 8.8* 1.9* 9.5 > 216*
Formic acid 2.7* 4.0* 10.8* 1.0* 5.5* 4.3*
5 0 3.2 4.6 6.3 0.7 3.0 186
L. brevis 4.1* 4.4* 8.8* 1.1* 2.8* 279
Formic acid 2.6 4.5* 1.8* 0.4* 2.1* 181
6 0 8.2 3.9 9.8 0.9 6.0 22
L. brevis 9.3* 3.9 9.3 1.8* 5.8* 261*
CFU: colony-forming units; DM: dry matter.
*: Signiﬁcantly different from the control value at p < 0.05.
(a): Period to reach 3°C rise over the ambient temperature (h).
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Documentation provided to EFSA
1) Lactobacillus brevis TAK 124-1 NCIMB 42149. Request for authorization according to
Regulation (EC) 1831/2003 Article 4(1). April 2015. Submitted by Bio-Competence Centre of
Healthy Dairy Products LLC.
2) Lactobacillus brevis TAK 124-1 NCIMB 42149. Request for authorization according to
Regulation (EC) 1831/2003 Article 4(1). Supplementary information August 2016. Submitted
by Bio-Competence Centre of Healthy Dairy Products LLC.
3) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for Lactobacillus brevis NCIMB 42149.
4) Comments from Member States.
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for Lactobacillus brevis NCIMB 4214927
In the current application authorisation is sought under Article 4(1) for Lactobacillus brevis TAK
124-1 NCIMB 42149 under the category/functional group 1(k) “technological additives”/“silage
additives”, according to Annex I of Regulation (EC) No 1831/2003. Speciﬁcally, authorisation is sought
for the use of the feed additive for all animal species. The feed additive is to be marketed as a powder
containing a minimum concentration of 1.0 9 1011 colony forming units (CFU)/g Lactobacillus brevis
TAK 124-1 NCIMB 42149. The original strain is deposited at NCIMB Ltd. (National Collection of
Industrial, Food and Marine Bacteria, Scotland). The feed additive is intended to be added to silage via
a water suspension at a minimum dose of 1.0 9 108 CFU/kg fresh silage.
For the identiﬁcation of Lactobacillus brevis TAK 124-1 NCIMB 42149, the Applicant submitted the
carbohydrate fermentation patterns (API system) and molecular methods: Internal Transcribed Spacer
Polymerase Chain Reaction (ITS-PCR) and Enterobacterial Repetitive Intergenic Consensus Polymerase
Chain Reaction (ERIC-PCR). However, the EURL recommends for ofﬁcial control Pulsed Field Gel
Electrophoresis (PFGE), a generally recognised standard methodology for microbial identiﬁcation.
For enumeration of Lactobacillus brevis TAK 124-1 NCIMB 42149 in feed additive, the Applicant
submitted a pour plate method based on the ring-trial validated CEN method (EN 15787). Based on
the performance characteristics available the EURL recommends for ofﬁcial control the CEN method for
the enumeration of Lactobacillus brevis TAK 124-1 NCIMB 42149 in the feed additive.
Since the accurate quantiﬁcation of Lactobacillus brevis TAK 124-1 NCIMB 42149 added to silage is
not experimentally achievable, the Applicant did not provide any experimental method or data.
Therefore, the EURL cannot evaluate or recommend any method for ofﬁcial control to quantify the
active substance in silage.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
27 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/ﬁles/ﬁnrep-FAD-2015-0014%
20AerobEst.pdf
Lactobacillus brevis NCIMB 42149 for all species
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